Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Patient Navigation × Plasma cell × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20 Breast 11 Thoracic 9 Gynecologic 6 Tumor-Agnostic 5 Other hematologic neoplasm 3 Lymphoid 3 Genitourinary 2 Plasma cell 1 Other solid neoplasm 1 Other 1 Head & Neck 1 Endocrine 1

Conditions

Multiple Myeloma 1 Lymphoma 1

Interventions

Cyclophosphamide 19 Dexamethasone 13 fludarabine phosphate 11 fludarabine 10 Peripheral Blood Stem Cell Transplantation 10 Cyclosporine 10 Whole-Body Irradiation 9 Exercise 9 Blood Specimen Collection 9 Antilymphocyte Serum 8 Mycophenolic Acid 7 Melphalan 7 Therapeutics 6 Standard of Care 6 Radiotherapy 6 Filgrastim 6 Busulfan 6 Bortezomib 6 Acupuncture Therapy 6 pomalidomide 5 Palliative Care 5 Educational Status 5 Behavior Therapy 5 daratumumab 4 Surveys and Questionnaires 4 Stem Cell Transplantation 4 Resistance Training 4 Psychiatric Rehabilitation 4 Practice Guidelines as Topic 4 Lenalidomide 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06063603 2025-09-18

ASCENT

Mayo Clinic

Phase NA Completed

51 enrolled 8 charts

LymphoidPlasma cell

Lymphoma, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡